Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial	Lewy body dementia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy	Recruiting	Phase 2	2026-05-05		NCT04588285

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Haraldsplass Deaconess Hospital	7
Helse Fonna	20
Helse Stavanger HF	67
Helse-Bergen HF	12
Klinbeforsk	8
Oslo University Hospital	327
St. Olavs Hospital	167
University Hospital of North Norway	93
University Hospital, Akershus	87

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Haraldsplass Deaconess Hospital	Bergen	Norway	2
Helse Fonna	Haugesund	Norway	1
Oslo University Hospital	Oslo	Norway	111
Stavanger University Hospital	Stavanger	Norway	36
Trondheim University Hospital	Trondheim	Norway	6
University Hospital North-Norway	Tromsø	Norway	1
University Hospital, Akershus	Hågån	Norway	1
University Hospital, Akershus	Lørenskog	Norway	3